Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-25-326996
Filing Date
2025-12-19
Accepted
2025-12-19 16:46:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 POS AM d41676dposam.htm POS AM 506134
2 EX-23.1 d41676dex231.htm EX-23.1 2705
3 GRAPHIC g41676g01k01.jpg GRAPHIC 63957
  Complete submission text file 0001193125-25-326996.txt   598369
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: POS AM | Act: 33 | File No.: 333-284606 | Film No.: 251588206
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)